Willow vs Layla

Bundled starting prices are simple, although prescription and dose changes can raise cost.

Layla's official pages contain material price conflicts, so no current starting rate is safe to publish.

Ongoing physician access supports continuity, with compounded-product caveats.

Independent clinicians review treatment, while product and pharmacy details require order-level confirmation.

A free online assessment leads to licensed physician review and pharmacy fulfillment.

The process is online, but patients need a saved checkout summary to resolve conflicting public terms.

Injection and oral compounded GLP-1 routes provide meaningful choice.

Semaglutide and tirzepatide-based options are marketed, with product identity requiring precise verification.

Shipping is included and a typical processing timeline is published.

Shipping is advertised as included, but official delivery windows conflict.

Unlimited physician messages and care-team access are core program features.

Ongoing support is promoted without a consistently documented response or resolution standard.

The online flow is cohesive, while price-change and cancellation details need care.

The front-end flow is simple, while contradictory content makes an informed checkout harder than it should be.